A Novel Treatment for Glioblastoma: Mesenchymal Stem Cells as Natural Bio-Factories for Exosomes Carrying miR-124a

Thumbnail Image

Files

Frederick Lang Undergraduate Thesis.pdf778.45 KB
Thesis Poster.pptx11.72 MB
lang-license.pdf349.33 KB

Date

2017-05

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

274
views
248
downloads

Abstract

There is currently no effective treatment for glioblastoma, the most common andmost deadly primary adult brain tumor. MicroRNAs (miRs), important post-transcriptionalregulators, represent a new class of anti-glioma agents. However, major unanswered problems in glioma therapy are which miRs will be most effective against tumor-homing glioma sphereforming cells (GSCs) and how these miRs will be delivered. Here, we build upon the recent observation that tumor-homing, bone marrow mesenchymal stem cells (MSCs) secrete exosomes, nano-sized vesicles that transport various cargoes, including miRs. We hypothesized that specific miRs can effectively treat GSCs and that these miRs can be delivered to glioblastomas using MSCs themselves or exosomes derived from ex vivo-cultured MSCs.

Type

Honors thesis

Department

Neurosurgery

Description

Provenance

Subjects

glioblastoma, mesenchymal stem cells

Citation

Permalink

https://hdl.handle.net/10161/16749

Published Version (Please cite this version)

https://doi.org/10.1093/neuonc/nox152

Collections

Undergraduate Honors Theses and Student papers
Full item page

Dukes student scholarship is made available to the public using a Creative Commons Attribution / Non-commercial / No derivative (CC-BY-NC-ND) license.